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 Abstract
Severe injury and hemorrhagic shock (HS) result in multiple changes to hematopoietic
differentiation, which contribute to the development of immunosuppression and multi-
ple organ failure (MOF). Understanding the changes that take place during the acute
injury phase may help predict which patients will develop MOF and provide potential
targets for therapy. Obtaining bone marrow from humans during the acute injury phase
is difﬁcult so published data are largely derived from peripheral blood samples, which
infer bone marrow changes that reﬂect the sustained inﬂammatory response. This pre-
liminary and opportunistic study investigated leucopoietic changes in rat bone marrow
6 h following traumatic injury and HS. Terminally anesthetized male Porton Wistar rats
were allocated randomly to receive a sham operation (cannulation with no injury) or
femoral fracture and HS. Bone marrow cells were ﬂushed from rat femurs and
immunophenotypically stained with speciﬁc antibody panels for lymphoid (CD45R,
CD127, CD90, and IgM) or myeloid (CD11b, CD45, and RP-1) lineages. Subsequently,
cell populations were ﬂuorescence-activated cell sorted for morphological assessment.
Stage-speciﬁc cell populations were identiﬁed using a limited number of antibodies, and
leucopoietic changes were determined 6 h following trauma and HS. Myeloid subpopu-
lations could be identiﬁed by varying levels CD11b expression, CD45, and RP-1.
Trauma and HS resulted in a signiﬁcant reduction in total CD11b + myeloid cells
including both immature (RP-1(−)) and mature (RP-1+) granulocytes. Multiple B-cell
lymphoid subsets were identiﬁed. The total percentage of CD90+ subsets remained
unchanged following trauma and HS, but there was a reduction in the numbers of
maturing CD90(−) cells suggesting movement into the periphery. © 2019 The Authors.
Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of
Cytometry.
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TRAUMATIC injury and hemorrhagic shock (HS) continues to be a leading cause of
mortality and morbidity in patients of all ages (1). One of the fundamental problems
in the weeks following trauma is severe inﬂammation and immune dysregulation,
which not only renders the host susceptible to infection, but leads to tissue damage
and ultimately multiple organ failure (MOF) (2–4). The bone marrow is responsible
for generating the immune, stromal, and endothelial cells involved in a post-
traumatic response (5). Any sustained inﬂammatory condition, for example, follow-
ing trauma, undoubtedly has an impact upon bone marrow function and
hematopoietic stem/progenitor cell proliferation and differentiation. A greater
understanding of how hematopoietic differentiation is altered following severe
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trauma may indicate which patients are more likely to
become immunosuppressed and enter into MOF and/or pro-
vide potential targets for treatment.
Hematopoietic stem cells (HSC) reside in stromal niches
in the bone marrow and, in response to the relevant cues,
generate a large, but diverse, population of mature functional
blood cells. These maturing cells move from the bone marrow
into the peripheral blood to replace lost or damaged cells and
maintain immune function (6). HSC differentiate into
multipotent progenitor cells, which become lineage restricted
with proliferation and maturation (7,8). This is accompanied
by a change in morphological appearance and a phenotypic
change in their surface expression of proteins, which aids in
identiﬁcation (9,10). With the exception of a very small num-
ber of immature progenitor cells that move between the bone
marrow and periphery to aid in repair, HSC and hematopoi-
etic progenitor cells (HPC) are not found within the periph-
eral circulation under normal circumstances (11).
Hematopoietic cells can be loosely divided into two main
lineages: myeloid, which generates granulocytes, monocytes/
macrophages, erythrocytes and platelets; and lymphoid, which
generates B cells that mature in the bone marrow and T cells
that mature in the Thymus (8). The initial granulocyte precur-
sors are virtually indistinguishable from monoblasts both mor-
phologically and immunophenotypically but differentiation
results in a series of morphological and immunophenotypical
changes, which can be identiﬁed (12). The bone marrow holds
a reserve pool of more mature (RP-1+ in rat) granulocytes
that can be rapidly mobilized into the peripheral circulation in
response to infection or trauma-induced stress (13). Once this
reserve has been diminished immature, and potentially dys-
functional, granulocytes are released in an attempt to maintain
immune function (14). Immature CD45R+ (B220), CD90+
and IL-7 receptor alpha (CD127) expressing pro-B lympho-
cytes reside in speciﬁc IL-7 expressing niches within the bone
marrow that support proliferation (6). These proliferative
niches are likely to increase in number in response to infection
and trauma-induced stress (13). Larger mitotically active pre-
B cells differentiate into smaller more independent cells that
lose CD127 expression and go on to become newly generated
IgM-expressing B cells (6).
Severe injuries, including HS, result in changes to lineage
maturation and movement of immature nonfunctional pro-
genitor cells into the peripheral circulation (15–18). Multi-
parameter ﬂow cytometry can be used to identify and
quantify hematopoietic cells at different stages of differentia-
tion using forward scatter (FSC: measure of cell size), side
scatter (SSC: a measure of granularity), and antibody panels
directed against lineage-speciﬁc cell surface antibodies (19).
In humans, blunt force trauma has been reported to suppress
bone marrow activity with a reduction in myeloid colony for-
mation (17,20) and CD34+ HSC/HPCs (21). However,
obtaining human bone marrow during the acute injury phase
is difﬁcult so most of the bone marrow data published infers
changes reﬂected during the sustained systemic inﬂammatory
response, or from the peripheral blood response. Identifying
changes in differentiation within each lineage during the
acute injury phase have been demonstrated (21) and could be
a useful tool to identify potential trauma patients who may be
likely to develop bone marrow failure as part of MOF.
We hypothesized that trauma and HS would result in
changes in the proﬁle of bone marrow hematopoietic progeni-
tors compared to those obtained after anesthesia alone. This
opportunistic study used multiparameter ﬂow cytometry to
investigate leucopoiesis in rat bone marrow during the acute
phase response to injury and HS. It focuses on both myeloid
and lymphoid changes that take place downstream of the
early blast-stage progenitors. Cell populations were conﬁrmed
by morphological assessment following ﬂuorescence activated
cell sorting.
MATERIALS AND METHODS
Legislation
This study was performed under the Authority of Animals
(Scientiﬁc Procedures) Act 1986 and was subject to local Ethi-
cal Review at the Defense, Science, and Technology Laborato-
ries (DSTL), Porton Down and at Swansea University
Medical School. This bone marrow investigation was an
opportunistic study as part of another ethically approved
study investigating a drug intervention to reduce inﬂamma-
tory consequences posttrauma.
Animals and Anesthesia
Male Porton Wistar rats (n = 18; 6–8 weeks, weight
223–260 g) were kept in standard conditions (temperature
20–24C, humidity 45–65% with 12 h light/dark cycles) and
fed LabDiet EURodetn Diet 22% ad libitum with free access
to water. The study was conducted under terminal anesthesia
(animals remained anesthetized throughout the procedure
and were killed humanely at the end of the study with an
overdose of anesthetic). Anesthesia was induced with iso-
ﬂurane in 100% oxygen in an induction chamber. Arterial
oxygen saturation was monitored by pulse oximetry (Starr
Life Sciences, Oakmont, PA) and body temperature
maintained at 38.5C using a thermostatically controlled
under-body heating blanket (Harvard Apparatus, Holliston,
MA). Surgical anesthesia was maintained using alfaxalone
(10 mg/ml, Alfaxan®, Jurox (UK) Limited, Crawley, UK)
given by continuous intravenous infusion (PHD Ultra Infu-
sion Pump, Harvard Apparatus, UK) via a 22G cannula
(BD Instye™) in lateral tail vein. The jugular vein was cannu-
lated with a 3 french cannula (Solomon Scientiﬁc). Arterial
blood pressure was monitored continuously via an implanted
femoral artery cannula (2F Solomon Scientiﬁc) using a strain
gauge manometer (Sensonor 840, SensoNor a.s., Norway) and
data acquisition system (MacLab 16/sp, ADInstruments, UK).
Anesthetized rats were allowed to stabilize for 30 min prior to
injury.
Trauma Model
Anesthetized rats were allocated randomly to receive a sham
operation (cannulation with no injury; n = 6) or subjected to
femoral fracture followed by HS (n = 12). After stabilization
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following anesthesia, the right femur was approached via a
skin incision and blunt dissection in preparation for femoral
fracture using bone cutters. The femur was fractured and
3 min later hemorrhage commenced. A target volume of 30%
of the animal’s estimated blood volume (2% per minute) was
taken from the femoral artery catheter into syringes con-
taining anticoagulant citrate phosphate dextrose, which was
stored at room temperature. The mean arterial blood pressure
was maintained at 40–45 mm Hg with either removal of
blood or administration of 0.9% saline. At 90 min resuscita-
tion, whole autologous blood was commenced to a target
mean arterial pressure of 70–80 mm Hg followed by an infu-
sion of colloid (GelofusinTM) at 8 ml/kg/h for the reminder
of the study. Six hours following injury, all animals were
killed humanely with an over dose of anesthetic (Euthatal,
Merial Animal Health Ltd, Harlow, UK). Immediately after
postmortem, one femur from each animal was excised and
put into DMEM (Gibco) and stored at 4–8C overnight prior
to transport to Swansea University on wet ice. Approximately
20 h elapsed between the femurs being recovered and the
bone marrow extraction.
Antibodies and Reagents
Immunophenotypical staining was used to identify the differ-
ent myeloid and lymphoid subpopulations during leucopoiesis
in rat bone marrow (Fig. 1).
Myeloid antibody markers: Anti-rat CD45-FITC (OX-1)
is a leukocyte-speciﬁc antigen expressed on all hematopoietic
cells except erythrocytes. Granulocyte-PE (RP-1) is expressed
on neutrophils during development and CD11b-APC (WT-5)
speciﬁcally binds to the α subunit of Mac-1 expressed on all
myeloid cells. These antibodies were obtained from BD Bio-
sciences (Oxford, UK).
Lymphoid antibody markers: CD90 (Thy1.1)-APC
(HIS51) is an early differentiation marker. CD45R (B220)-
FITC (HIS24) is expressed on developing B lymphocytes, and
IgM-PE (HIS40) is expressed on the more mature B cells dur-
ing development. These antibodies were purchased from
eBioscience (Thermo Fisher Scientiﬁc, UK). CD127 (rIL-7Rα)-
PE is expressed on pre-B cells during early development,
which along with puriﬁed rat IgG was obtained from R&D
Systems, UK.
EasyLyse lysis buffer was obtained from Dako (Agilent
Technologies) UK. Alpha-Minimal Essential Media (Alpha-
MEM) with GlutaMAX supplement and Fetal Bovine
Serum (FBS) was obtained from Gibco (Thermo Fisher
Scientiﬁc) UK.
Isolating Bone Marrow Cells
The in-tact femurs were cleared of all soft tissue and the fem-
oral head and epiphysis were removed to allow for bone mar-
row collection. Bone marrow cells were isolated by ﬂushing
each femur from both ends, ﬁrstly with approximately 5 ml
FBS and then using 10 ml Alpha-MEM with a 21-gauge nee-
dle and syringe. The cells were washed and resuspended in
Alpha-MEM 10% FCS. A total nucleated cell count was
determined using the Countess automated cell counter
(Thermo Fisher Scientiﬁc, UK).
Flow Cytometry
One million cells/100 μl were incubated with 10 μl puriﬁed
Rat IgG per ﬂow cytometry tube for 15 min at room tempera-
ture. The cells were subsequently incubated on ice for 30 min
with preoptimized concentrations of antibodies to identify
myeloid (2.5 μg CD45 (OX-1)-FITC, 1 μg Granulocyte (RP-
1)-PE, & 1 μg CD11b (WT-5)-APC) or lymphoid populations
(2.5 μg CD45R (HIS24)-FITC, 0.2 μg IgM (HIS40)-PE, 0.5 μg
IL-7Rα/CD127-PE & 0.06 μg CD90 (HIS51)-APC). Non-
speciﬁc isotype-matched controls were included as control.
Red blood cells were lysed by incubating for 15 min in the
dark at room temperature with 3 ml EasyLyse. The cells were
washed in FACS buffer (PBS with 0.2% bovine serum albu-
min and 0.05% sodium azide), ﬁxed in 0.1% paraformalde-
hyde, and the data were acquired on a ﬂow cytometer (FACS
Aria I, BD Biosciences) within 24 h. Single-stained samples
were used for automated compensation matrices. The data
were analyzed using Kaluza® software (Beckman Coulter).
Myeloid populations were analyzed in 6 surgical control
(no injury) rats and in 12 injured (femoral fracture and HS)
rats. Thirty thousand events were acquired. Debris, Eosino-
phils, and smaller Lymphocyte and blast populations were
excluded by gating (Fig. 2 Gate A). All gated cells expressing
the myeloid marker CD11b were analyzed for CD45 and RP-
1 expression.
Lymphoid populations were analyzed in ﬁve surgical
control rats and eight injured rats. Hundred thousand events
were acquired. Debris, Granulocytes, and Eosinophils were
largely excluded by gating (Fig. 4 Gate A). Various lymphoid
populations were selected based on CD127 and CD45R posi-
tivity and FSC v SSC expression (Fig. 4 Gate B).
Flow Sorting and Cytospin Preparation
Following ﬂow cytometric analysis, randomly selected sam-
ples were chosen for ﬂuorescence-activated cell sorting (FACS
Aria I, BD Biosciences) and cytospin preparation. The mye-
loid cell populations were sorted using the FACS Aria I and
used to prepare cytospins for morphological assessment. A
high pressure sort (70 psi) with the 70-μm nozzle was used.
Myeloid populations (Fig. 2) were sorted (up to 10,000
events) into ﬂow cytometry tubes using a ﬂow rate of approx-
imately 2000 events/s. Each sorted cell population was made
up to 50 μl in FACS buffer and transferred to cytospin cham-
bers attached to labeled microscope slides. The cytospins were
centrifuged for 3 min at 1000 rpm (Cytospin3, Thermo Sha-
ndon); air dried and stained using an automated Hematology
slide preparation unit (Sysmex SP-10), which ﬁxes the slides
in Methanol and stains using May Grunwald and Giemsa (tcs
biosciences, UK). Slides were air dried and DPX mounted.
The cytospins were viewed at 100x magniﬁcation under oil.
Statistical Analysis
Data are represented as median +/− percentiles (box) and
min-max range (whiskers). All data were subjected to
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nonparametric statistics due to the small sample size, includ-
ing Mann–Whitney U test for bivariate analysis, with
P < 0.05 deemed to be statistically signiﬁcant. The graphics
and data were analyzed using Statistica 6 (StatSoft).
RESULTS
Characterizing Myeloid Populations
Rat bone marrow-derived cells were analyzed using FSC, SSC,
CD11b (WT-5), Granulocyte (RP-1), and CD45 (OX-1).
Using the FSC and SSC plot eosinophils, smaller lymphocytes,
blast populations, possible doublets and debris were excluded
from the analysis (Fig. 2A, Gate A) to focus on characterizing
neutrophils and monocytes. The myeloid cells were gated on
CD11b (Fig. 2B, Gate B). Maturing Neutrophils-stained posi-
tively for the granulocyte marker RP-1 (Fig. 2B,C), which
alongside CD11b expression, increased in ﬂuorescent inten-
sity with maturity (Fig. 2B Gate B). Two granulocyte (RP-1)
negative subpopulations were identiﬁed within the CD11b
+ myeloid population (Fig. 2C). One RP-1(−) subpopulation
showed high expression for CD45 (CD45+++; Fig. 2C) with
low SSC (Fig. 2D). The other RP-1(−) sub-population had a
similar SSC and CD45 expression to RP-1+ neutrophils but
were larger in size (higher FSC, Fig. 2A). These populations
Figure 1. Simpliﬁed schematic diagram showing myeloid and lymphoid haemopoietic differentiation with CD nomenclature for ﬂow
cytometry identiﬁcation in rat bone marrow. [Color ﬁgure can be viewed at wileyonlinelibrary.com]
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were isolated using ﬂow sorting, and cytospins were used to
characterize their morphology (Fig. 2C1-C3).
The RP-1 marker is expressed on band form and mature
neutrophils (Fig. 2 C2). The segmentation of the nuclei is not
as pronounced in rat as it is in human, and the rat neutrophils
are smaller at approximately 5 μm in diameter. Granulation
can be observed within the cytoplasm accounting for the high
SSC. The RP-1(−) subpopulation with high SSC and lower
CD45 expression are immature granulocytes (Fig. 2 C3). These
cells were much larger than the mature neutrophils at approxi-
mately 10 μm in diameter, accounting for the larger FSC and
are granular in nature (SSC expression). Promyelocytes and
myelocytes were identiﬁed with round to oval nuclei as well as
metamyelocytes that had a more-indented nuclei. Their cyto-
plasm stained much darker than the RP-1+ neutrophils from
coarse granulation. They stained positively for CD11b expres-
sion but had not yet developed the RP-1 marker on the sur-
face of their cells. The other RP-1(−) subpopulation with high
CD45 expression and low SSC were more variable in nature.
These were identiﬁed as monocytes (Fig. 2 C1). They were
between 5 and 10 μm in diameter with a high nuclear to
cytoplasmic ratio, which was convoluted and irregular in
shape. The cells were darkly stained and vacuolar but were
agranular accounting for the low SSC. There was some con-
tamination of immature granulocytes within this population
following ﬂow sorting.
Effect of Trauma and HS on Myeloid Populations
Trauma and HS had a signiﬁcant impact on the myeloid pop-
ulation within rat bone marrow. The total percentage of
CD11b + myeloid cells (Fig. 3A), RP-1+ neutrophils (Fig. 3B),
and immature RP-1(−) neutrophils (Fig. 3C) were all signiﬁ-
cantly reduced 6 h following trauma in rat bone marrow. The
population of RP-1(−) CD45+++ monocytes were not affected
6 h following trauma (Fig. 3D). The proportion of neutrophils,
monocytes, and immature granulocytes within the CD11b
+ myeloid population remained unchanged following trauma.
Characterizing B-Cell Lymphopoiesis
Rat bone marrow-derived cells were analyzed using FSC, SSC,
CD45R (HIS24), CD90 (HIS51), CD127 (rIL-7Rα), and IgM
(HIS40). Using the FSC and SSC plot Eosinophils, Neutrophils,
Figure 2. One million rat bone marrow cells were stained with CD11b-APC, granulocyte (RP-1)-PE, and CD45-FITC. Thirty thousand events
were taken, and the data were analyzed using Kaluza. Debris, eosinophils, blasts, and some lymphocytes were excluded from the analysis
(A Gate A). CD11b + myeloid cells were gated (B Gate B). RP-1+ neutrophils were identiﬁed (C). Using SSC and CD45, it was possible to
split the RP-1(−) cells into two sub-populations: Monocytes (low SSC and high CD45 expression) and immature granulocytes (high SSC
and low CD45 expression) (C,D). The monocytes were identiﬁed immediately below the RP-1+ granulocytes on the FSC versus SSC plot
(A). The immature granulocytes were larger than the RP-1+ neutrophils with a higher FSC (A). The CD11b + sub-populations were isolated
using Fluorescent Activated Cell Sorting and used to prepare cytospins. The cytospins were stained with May-Grunwald Giemsa. More
than 90% of RP-1+ events stained for band form to polymorphonuclear neutrophils (C2). More than 90% of the RP-1(−), low CD45, high
SSC, high FSC cells stained for the larger immature granulocytes, which had oval or crescent moon nuclei and prominent cytoplasmic
granulation (C3). The morphology of the RP-1(−), high CD45, low SSC sub-population was more variable (C1). Cells and nuclei were more
irregular in shape with a high nuclear to cytoplasmic ratio. This population likely consists of a mixture of immature to mature monocytes.
There may also be some overlap with the immature granulocytes with some cells appearing to have some granulation in the cytoplasm.
[Color ﬁgure can be viewed at wileyonlinelibrary.com]
Cytometry Part A  95A: 1167–1177, 2019 1171
ORIGINAL ARTICLE
possible doublets and debris were largely excluded from the analy-
sis (Fig. 4, Gate A) to focus on characterizing Lymphocytes.
Monocyte contamination was excluded using CD45R.
Three populations were characterized using CD45R and
CD127: CD45R+ CD127+ (Fig. 4A), CD45R+ CD127(−)
(Fig. 4B) and CD45R+++ CD127(−) (Fig. 4C). The CD45R+
CD127+ (Fig. 4A) population were larger in size and stained
intensely for CD90. CD90 expression reduced with the loss of
CD127. The CD45R+ CD127(−) population (Fig. 4B) was diverse
and varied in size (FSC), granularity (SSC), and CD90 expression,
therefore, this population was further split using FSC and SSC for
statistical analysis (Fig. 5B). The CD45R+++ CD127(−)
population (Fig. 4C) formed 1 clear population on the FSC SSC
plot (Gate A) and were variable for CD90 expression.
IgM was used as a marker of maturity. IgM positivity
increased with CD45R expression so CD45R+++ cells were
strongly positive for IgM (Fig. 4D). Cells staining intensely
for CD90 were IgM(−) and correlated with CD127+ cells.
The variable CD45R+ CD127(−) population showed an
increasing expression of IgM with maturation.
Effect of Trauma and HS on B-Cell Lymphopoiesis
The CD45R+ CD127(−) subset (Fig. 5B) was subdivided
according to FSC/SSC for analysis due to its heterogeneous
Figure 3. The total percentage of CD11b + myeloid cells (A), RP-1+ neutrophils (B), and immature RP-1(−) high SSC/FSC granulocytes
(C) were signiﬁcantly reduced in rat bone marrow 6 h posttrauma (T) in comparison to the surgical control (SC) population. There was no
difference in the total percentage monocytes (D) following trauma. Data graphically represented as median +/− percentiles (box) and min-
max (whisker). Signiﬁcance denoted as P < 0.05.
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expression. No signiﬁcant differences were observed between
the SC and Trauma groups in the subpopulations with low
FSC/SSC or large FSC/SSC (data not shown). Subpopulation
C (Fig. 4B) was used for statistical analysis. Looking at the
bone marrow as a whole, trauma and HS had little impact on
the total percentage of CD45R+ CD127+ (Fig. 5 A1), CD45R
CD127(−) (Fig. 5 B1) or CD45R+++ CD127(−) (Fig. 5 C1)
cells expressing CD90 in comparison with the surgical control
group. Trauma and HS, however, resulted in a signiﬁcant
reduction in the total percentage of cells with weak or no
expression of CD90 (Fig. 5 B2,C2). These were very small
populations but may represent movement out of the bone
marrow into the periphery.
Looking more speciﬁcally at the populations identiﬁed,
the CD45R+ CD127+ subset showed a signiﬁcantly reduced
proportion of CD90+ cells following trauma and HS (Fig. 5
A3). In contrast, both the CD45R+ CD127(−) (Fig. 5 B3) and
CD45R+++ CD127(−) (Fig. 5 C3) populations showed an
increase in the gated percentage of CD90+ cells.
DISCUSSION
This study identiﬁed subpopulations of cells at different levels
of maturity within rat bone marrow using a limited number
of antibodies. It also established an acute phase response to
trauma demonstrating a rapid change in bone marrow lineage
Figure 4. One million rat bone marrow cells were stained with CD45R-FITC, CD127-PE, CD90-APC or CD45R-FITC, IgM-PE, CD90-APC. Up to
100,000 events were taken, and the data analyzed using Kaluza. Debris, eosinophils, and neutrophils and blasts were excluded from the analysis
(Gate A). Three populations were identiﬁed using CD45R and CD127: A) CD45R+ CD127+, B) CD45R+ CD127(−), and C) CD45R+++ CD127(−).
CD45R+ CD127+ (A) lymphocytes were larger (higher FSC) than the CD45R+ CD127(−) (B) cells; stained intensely for CD90 and CD127 and was
negative for IgM. CD90 expression reduced with the loss of CD127. With differentiation CD45R+ lymphocytes lost CD127 expression and increased
their CD45R (C) and IgM positivity (D). CD45R+ CD127(−) (B) cells represented a heterogeneous population, whereas the CD45R+++ CD127(−)
(C) lymphocytes identiﬁed one speciﬁc population on the FSC v SSC plot (Gate A). [Color ﬁgure can be viewed at wileyonlinelibrary.com]
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differentiation to meet the innate requirements of the periph-
ery. We have previously shown in humans a depletion of the
CD34+ hematopoietic progenitors in the bone marrow one to
two weeks following major trauma, which was speciﬁcally
narrowed down to the less primitive CD34+ CD38bright frac-
tion (21). This may be related to an increased demand due to
Figure 5. The total percentage of CD45R+ CD127+ CD90+ (A1), CD45R+ CD127(−) CD90+ (B1), and CD45R+++ CD127(−) CD90+ (C1) cells
within rat bone marrow remained unchanged 6 h following trauma and HS. The analysis of CD45R+ CD127(−) (B) was restricted to sub-
population C (Fig. 4) due to the heterogeneous nature of the population. The gated percentage of CD90+ cells within CD45R+ CD127(−)
(A3) population was signiﬁcantly reduced following trauma and HS, while the gated percentage of CD90+ cells within the more mature
CD45R+ CD127(−) population was signiﬁcantly increased (B3). Trauma and HS resulted in a signiﬁcant reduction in the total percentage of
CD45R+ CD127(−) CD90(−) (B2) and CD45R+++ CD127(−) CD90(−) (C2) populations. Data graphically represented as median +/−
percentiles (box) and min-max (whisker). Signiﬁcance denoted as P < 0.05.
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sustained inﬂammation, particularly in extremis patients, to
generate more lineage-restricted progenitors and maturing
immune cells with depletion of pluripotential progenitors. We
sought to understand those changes during the acute phase
response to trauma but obtaining bone marrow from humans
within hours of trauma is difﬁcult. This opportunistic study
in rats enabled us to study hematopoietic changes in bone
marrow within 6 h of blunt force trauma and HS. The study
was limited by the lack of compatibility of cell surface
markers in comparison to human, preventing a direct com-
parison, and from a lack of availability of rat-speciﬁc anti-
bodies, which can limit the ability to elucidate different
lineage strands. However, we successfully identiﬁed different
stage-speciﬁc leucopoiesis with a small number of cell surface
markers and established changes during the acute phase
response to trauma.
Myeloid cells were identiﬁed using CD11b (WT-5),
which forms an integrin molecule with CD18 to mediate leu-
kocyte adhesion, migration, and innate immune function. It
is commonly expressed on granulocytes, monocytes, and nat-
ural killer cells at different stages of maturity and can be
found on a subset of B-lymphocytes (22). In this study, no
lymphocytes were demonstrated morphologically within the
myeloid gates (Fig. 2), and there was no coexpression of
CD45R and CD11b (data not shown). Myeloblasts, progeni-
tors for both the granulocytic and monocytic lineages (Fig. 1),
are CD11b(−) and indistinguishable immunophenotypically
between lineages (12). CD11b, therefore, identiﬁed the
lineage-speciﬁc myeloid subpopulations. Rat granulocytes
comprised of eosinophils, which were eliminated from the
analysis based on their high SSC (Fig. 2), and the more abun-
dant RP-1+ neutrophils. RP-1 was used in combination with
CD45 and SSC to separate the mature neutrophils from RP-1
(−) immature granulocytes. An intermediate CD45 expression
and high SSC were used to discriminate between immature
RP-1(−) granulocytes and CD45bright monocytes or lympho-
cytes (12). Morphologically all RP-1+ cells were mature poly-
morphonuclear neutrophils or band form (Fig. 2 c2), while
>90% of RP-1(−) CD45 intermediate cells with high SSC were
larger immature granulocytes (myelocytes to met-
amyelocytes). RP-1 proved to be a good speciﬁc granulocyte
marker in comparison to HIS48, which showed cross-
reactivity with monocytes (data not shown) (23).
B-lineage lymphocytes were identiﬁed based on their
expression of CD45R (B220), a marker consistently present on
B-lineage cells in mice (24) and rats (25). Differentiation was
quantitated on the level of CD45R expression, which increased
with maturity, and the presence of CD127 (large pre-B) or
IgM (newly formed and maturing cells). CD45R+++
expressing cells are reported to be terminally differentiated
lymphocytes while CD90, a Thy-1 membrane glycoprotein, is
found on immature B lymphocytes in rat (25). CD127+ cells
stained intensely for CD90 and a loss of CD127 expression
was reﬂected by a reduction in CD90 with differentiation.
CD127 is part of the IL-7 receptor, expressed from early small
pro-B cell to the larger pre-B stage and is downregulated with
differentiation to the small pre-B cell stage (26). This
corresponds to the larger (high FSC) cells staining intensely
for CD90 and CD127 and cell size diminishing as the expres-
sion of these markers reduced. The immature CD127+ cells
are reliant on IL-7, secreted by stromal cells, for proliferation
and differentiation. Mouse knock-out models have demon-
strated that early B and T-cell development is blocked in the
absence of IL-7Rα (27), therefore CD127, in the presence of
CD45R, is a good marker for early B cell development.
Within the CD45R+ CD127+ gate (Fig. 4A), there were
a small number of cells that weakly expressed CD45R and
CD127 and were CD90 low or negative. It is unclear what
these cells were but they were increased following trauma and
HS. Could these CD127weak CD45Rweak cells form an early
subset of B cell development prior to acquiring CD90 expres-
sion? CD127 is one of the earliest markers of B-cell lineage
commitment, prior to developing B-cell lineage markers such
as CD19 (28,29).
Both CD45R+ CD127(−) and CD45R+++ CD127(−)
populations were subdivided into CD90+ and CD90(−) sub-
sets (Fig. 4). The CD45R+++ CD127(−) CD90+ population
clearly identiﬁed as newly formed B cells and expressed high
levels of IgM (30,31). The CD45R+ CD127(−) population
(Fig. 4B) was heterogeneous in terms of size, granularity, and
CD90 expression, indicating the inclusion of cells at different
stages of differentiation. To further delineate this population,
more lineage-speciﬁc antibodies and ﬂuorescent channels
would be needed. For a more deﬁned analysis, FSC/SSC was
used to separate the population into three subpopulations.
Subpopulation C (Fig. 4) is likely developing into newly
formed B cells. These cells have similar FSC/SSC expression
proﬁles and express equivalent levels of CD90 but have not
developed high levels of CD45R and IgM expression. Newly
formed B cells give rise to follicular B cells, which characterize
as CD45Rbright, CD90(−) IgM(low) (30,31) These cells can be
identiﬁed in Figure 4 and are signiﬁcantly lost from the bone
marrow (Fig. 5 B2,C2), presumably into the periphery, follow-
ing trauma and HS.
Traumatic injuries and HS lead to complex multisystem
abnormalities that interplay with one another (4). Under-
standing the acute phase response to trauma in humans is
difﬁcult so rat trauma and HS models offer a prime alterna-
tive. They closely mimic that of the human response to
trauma and are useful to investigate systemic changes and
potential immunomodulatory treatments (32). A HS period
of 90 min and subsequent resuscitation aligns with that of
humans following severe injuries and is sufﬁcient to mount a
substantial systemic response (33).
It is well known that neutrophils are the primary effector
cell in a systemic inﬂammatory response following trauma or
sepsis, which results in a loss of natural immunity and causes
tissue damage (34–36). Within the ﬁrst hour following injury,
there is a ﬂux of neutrophils from the marginal pools along
the endothelium and the bone marrow into the circulation
(14), which remains high depending on the severity of injury
and subsequent surgical interventions (17,37). This study
showed a marked reduction in bone marrow CD11b +
myeloid cells within 6 h of trauma and HS, which suggests
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movement out into the periphery (14,20). Both mature RP-1+
and immature RP-1(−) granulocytes were signiﬁcantly
reduced, but monocytes appeared unaffected by 6 h. This
may be because monocytes respond later to injury, but they
are also suppressed following trauma, particularly in patients
who have a poor prognosis (38,39). The movement of imma-
ture cells into the periphery following injury has important
consequences if those cells are unable to provide the same
natural immunity as mature cells (40). Myeloid-derived sup-
pressor cells (MDSC) are a population of granulocytic/mono-
cytic precursors that accumulate systemically in response to
tumors, traumatic stress, or infection to suppress T-cell
responses in mice or humans (41–43). This study identiﬁed a
reduction in the total percentage of immature RP-1(−)
granulocytes from rat bone marrow following trauma and HS
but identiﬁcation of MDSCs in rat have proved challenging
and this study did not demonstrate MDSC function. Dolen
et al. (44) identiﬁed mature multilobed RP-1+ HIS-48+ gran-
ulocytic cells that could suppress CD4+ T-cell proliferation in
tumor-bearing rats. Mobilization of RP-1(−) progenitors into
the peripheral circulation likely augments repair after trauma
(16) and prevents immune-mediated damage through sup-
pression of T cell responses (41). If this persists for prolonged
periods, bone marrow suppression and ultimately failure will
result.
Lymphocyte counts have been reported to be increased
during the ﬁrst 12 h following trauma in humans (14). Rats
have a reverse differential in the peripheral blood with
approximately 10–20% neutrophils and 70–80% lymphocytes
(45,46), so it is possible there is a greater impact on lympho-
cyte egression and function in rats than in humans. Trauma
and HS had no impact on the numbers of CD90+ developing
B lymphocytes within rat bone marrow, but there was a sig-
niﬁcant reduction in the total numbers of maturing CD127
(−) CD90(−) cells. This was offset by an increase in the gated
percentage of CD90+ cells, suggesting movement of the more
mature CD90(−) populations into the periphery. In contrast,
the early CD127+ population showed an increase in the total
percentage of CD90(−) cells with a concomitant decrease in
the gated percentage of CD90+ cells. This may suggest move-
ment between compartments within the bone marrow to push
differentiation and maintain homeostasis 6 h following
trauma and HS.
The extent of adaptation within the bone marrow is likely
related to the severity of traumatic injury. The sympathetic ner-
vous system, which regulates the body’s response to trauma,
can directly interact with immune cells through adrenergic
receptors (15,47). Trauma, HS, and subsequent release of
proinﬂammatory cytokines can result in a sustained increase in
circulatory norepinephrine, which can suppress the growth and
differentiation of hematopoietic progenitors, particularly ery-
throid progenitors, and facilitate their mobilization out of the
bone marrow (48–50). Blocking the adrenergic receptors in
Sprague–Dawley rats was shown to restore progenitor function
(15,51). Despite the effect on early progenitors, the use of vaso-
pressors, such as norepinephrine, in the management of trauma
patients with HS remains controversial with some trauma
centers continuing to use them. Further randomized control
studies are required to determine any beneﬁt (52).
Identifying a reduction of hematopoietic progenitors
within the bone marrow and increases in immature cells
within the peripheral circulation may provide indicators of
bone marrow dysfunction. Admittedly these ﬁndings in rat
may not be directly transferable to human, but previous
human studies have identiﬁed impaired progenitor growth in
the bone marrow (21) and release of immature granulocytes
into the peripheral circulation (14,20). There is the potential
for cellular therapies, which may provide many beneﬁts post-
trauma, for example, transfused HSCs and/or mesenchymal
stromal cells may have regeneration properties, reduce
inﬂammation and help prevent bone marrow failure (53–55).
There may also be the potential to use therapeutic drugs such
as Erythropoietin, which besides driving erythropoiesis, has
shown antiinﬂammatory, cytoprotective, and antiapoptotic
beneﬁts (56,57).
This was a preliminary study, which identiﬁed stage-
speciﬁc differentiation in rat bone marrow using a limited
number of ﬂuorescence channels and cell-surface markers
and elucidated changes within the bone marrow within 6 h of
trauma and HS. Both the myeloid and lymphoid compart-
ments were signiﬁcantly modiﬁed in the acute phase response
to trauma and HS, and the proliferation/differentiation of
early progenitors was suppressed. Later stage immune cells
were mobilized into the peripheral circulation to maintain the
inﬂammatory response, while early progenitors may have
been lost to the circulation to aid in repair and prevent
immune-mediated damage by T cells. Further work needs to
be done, using more ﬂuorescent channels and cell surface
markers, to draw out the CD45R+ CD127(−) mixed popula-
tion and determine the impact of trauma on MDSC in rat
bone marrow and peripheral blood.
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